|
|
|
|
|
|
|
|
Gitlife Biotech Ltd
|
|
|
|
|
|
Notes to the financial statements
|
|
|
for the year ended 28 August 2026
|
|
|
|
|
|
|
|
|
1
|
Company information
|
|
|
|
|
|
|
|
|
|
Gitlife Biotech Ltd is a private company registered in England and Wales. Its registered number is 14690170. The company is limited by shares. Its registered office is 3rd Floor Maybrook House, 27-35 Grainger Street, Newcastle Upon Tyne, NE1 5JE.
|
|
|
|
|
|
|
|
|
2
|
Accounting policies
|
|
|
|
|
|
|
|
|
|
Basis of preparing the financial statements
|
|
|
|
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
|
|
|
|
|
|
|
|
|
|
Going concern
|
|
|
|
The company’s continued operation was dependent on securing additional funding by 31 August 2026. The directors had determined that, if sufficient funding was not secured by that date, the company would cease its activities and proceed with a voluntary liquidation. The required funding was not secured, and the directors are consequently pursuing a solvent voluntary liquidation. Although the directors expect the company to settle its liabilities in full, they consider that preparation of the financial statements on a going concern basis is no longer appropriate given their intention to liquidate the company. The financial statements have therefore been prepared in accordance with FRS 102, including Section 1A, on a basis other than going concern.
|
|
|
|
|
|
|
|
|
|
Turnover
|
|
|
|
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
|
|
|
|
|
|
|
|
|
|
Intangible assets
|
|
|
|
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
|
|
|
|
|
|
|
|
Amortisation is provided at the following annual rates in order to write off each asset over its estimated useful life.
|
|
|
|
|
|
|
|
Patents and licences
|
-
|
15 years straight line
|
|
|
|
|
|
|
|
|
|
Tangible fixed assets
|
|
|
|
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
|
|
|
|
|
|
|
|
Plant and machinery etc.:
|
|
|
|
Computer equipment
|
-
|
3 years straight line
|
|
|
|
|
|
|
|
|
3
|